-
New Zealand 231-9 as 'old school' West Indies exploit pace-friendly wicket
-
England spinner Jacks replaces injured Wood for second Ashes Test
-
Pope Leo to hold Beirut mass, visit port blast site
-
Australia opener Khawaja out of second Ashes Test with injury
-
Concern as India orders phone manufacturers to preload govt app
-
French talent Kroupi 'ready to suffer' to realise Premier League dream
-
New Zealand 231-9 as West Indies exploit bowler-friendly wicket
-
US Republicans sweat toss-up election in traditional stronghold
-
'Rescued my soul': Hong Kong firefighters save beloved pets
-
Suns eclipse shoddy Lakers, Mavs upset Nuggets
-
Seven footballers in Malaysia eligibility scandal 'victims': union
-
Patriots on brink of playoffs after Giants rout
-
Survivors, families seek answers to deadly Hong Kong ferry disaster
-
Race to get aid to Asia flood survivors as toll nears 1,200
-
Rugby World Cup draw: who, how and when?
-
Williamson falls for 52 as NZ reach 128-5 in West Indies Test
-
Hong Kong leader announces 'independent committee' to probe fire
-
South Korean leader calls for penalties over e-commerce data leak
-
Samsung unveils first 'special edition' triple-folding phone
-
Apple AI chief leaving as iPhone maker plays catch-up
-
Asian markets rise as US rate cut bets temper Japan bond unease
-
Weight of history against England in pink-ball Gabba Ashes Test
-
How South Korea's brief martial law upended lives
-
VR headsets take war-scarred children to world away from Gaza
-
'We chose it': PKK fighters cherish life in Iraq's mountains
-
US envoy to meet Russia's Putin for talks on ending Ukraine war
-
Pope Leo holds Beirut mass and visits site of port blast
-
'Quad God' Malinin ramps up Olympic preparations at Grand Prix Final
-
New Zealand 17-1 at lunch in rain-hit West Indies Test
-
Pacific island office enabling sanctions-busting 'shadow fleets'
-
White House gets scaled-down Christmas display amid ballroom work
-
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
-
White House confirms admiral ordered 2nd strike on alleged drug boat
-
Nigeria's defence minister resigns amid security crisis: presidency
-
From Honduras to Poland, Trump meddles in elections as never before
-
Trump holds Venezuela meeting as Maduro rejects 'slave's peace'
-
12 dead, dozens missing as landslide submerges boats in Peru port
-
Vardy's first Serie A double fires Cremonese past high-flying Bologna
-
Rich art: French pastry chefs auction chocolate sculptures
-
Cameroon sack coach Brys, drop goalkeeper Onana for AFCON
-
Son of Mexican crime lord 'El Chapo' pleads guilty in drug case: US media
-
Right-wing rivals for Honduras presidency in 'technical tie'
-
US upbeat on pushing Ukraine deal as envoy heads to Russia
-
European rocket puts S.Korean satellite in orbit
-
Trump to meet top national security team on Venezuela
-
US Supreme Court hears major online music piracy case
-
Pope gets rockstar welcome as he delivers message of hope to Lebanese youth
-
Iran sentences director Jafar Panahi to year in prison: lawyer
-
ICC vows to stand firm amid US sanctions
-
US to zero out tariffs on UK pharma under trade deal
| RBGPF | 1.54% | 79 | $ | |
| SCS | 0.55% | 16.38 | $ | |
| RYCEF | -2.68% | 13.83 | $ | |
| CMSC | -0.39% | 23.32 | $ | |
| GSK | -1.42% | 47.19 | $ | |
| VOD | -2.8% | 12.13 | $ | |
| RELX | -1.23% | 39.72 | $ | |
| RIO | 0.03% | 71.97 | $ | |
| NGG | -0.61% | 75.65 | $ | |
| CMSD | -0.13% | 23.29 | $ | |
| AZN | -2.44% | 90.52 | $ | |
| BCE | -0.09% | 23.49 | $ | |
| JRI | -0.15% | 13.78 | $ | |
| BCC | -1.18% | 75.13 | $ | |
| BTI | -0.91% | 58.13 | $ | |
| BP | 1.12% | 36.51 | $ |
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
F.Müller--BTB